Ironwood Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.12M Buy
47,608
+400
+0.8% +$46.8K 0.8% 36
2026
Q1
$5.68M Sell
47,208
-2,937
-6% -$339K 0.82% 40
2025
Q4
$5.28M Sell
50,145
-4,722
-9% -$443K 0.74% 44
2025
Q3
$4.61M Sell
54,867
-11,039
-17% -$909K 0.67% 44
2025
Q2
$5.22M Sell
65,906
-8,757
-12% -$696K 0.81% 39
2025
Q1
$6.7M Buy
74,663
+2,548
+4% +$238K 1.16% 20
2024
Q4
$7.17M Sell
72,115
-1,869
-3% -$193K 1.23% 17
2024
Q3
$8.4M Buy
73,984
+737
+1% +$87.6K 1.4% 14
2024
Q2
$9.07M Sell
73,247
-542
-0.7% -$69.8K 1.62% 10
2024
Q1
$9.74M Buy
73,789
+510
+0.7% +$62.9K 1.7% 8
2023
Q4
$7.99M Sell
73,279
-490
-0.7% -$50.9K 1.49% 14
2023
Q3
$7.59M Buy
73,769
+563
+0.8% +$60.7K 1.6% 12
2023
Q2
$8.45M Buy
73,206
+620
+0.9% +$70.4K 1.9% 5
2023
Q1
$7.72M Sell
72,586
-627
-0.9% -$67.7K 1.84% 8
2022
Q4
$8.12M Buy
73,213
+874
+1% +$89.3K 1.97% 6
2022
Q3
$6.23M Buy
72,339
+809
+1% +$72.2K 1.78% 11
2022
Q2
$6.52M Buy
71,530
+1,309
+2% +$116K 1.83% 11
2022
Q1
$5.76M Buy
70,221
+30,004
+75% +$2.37M 1.41% 20
2021
Q4
$3.08M Buy
40,217
+1,187
+3% +$94.5K 0.7% 45
2021
Q3
$2.93M Buy
39,030
+1,523
+4% +$116K 0.75% 41
2021
Q2
$2.92M Buy
37,507
+658
+2% +$48.9K 0.77% 40
2021
Q1
$2.71M Sell
36,849
-3,309
-8% -$244K 0.78% 43
2020
Q4
$3.13M Buy
40,158
+1,709
+4% +$131K 0.71% 47
2020
Q3
$3.04M Buy
38,449
+1,584
+4% +$124K 0.82% 41
2020
Q2
$2.72M Buy
36,865
+2,272
+7% +$171K 0.83% 37
2020
Q1
$2.54M Buy
34,593
+11,252
+48% +$884K 1% 33
2019
Q4
$2.02M Buy
23,341
+92
+0.4% +$7.56K 0.69% 47
2019
Q3
$1.87M Sell
23,249
-215
-0.9% -$17.2K 0.69% 49
2019
Q2
$1.88M Buy
23,464
+188
+0.8% +$14.4K 0.72% 47
2019
Q1
$1.85M Buy
23,276
+593
+3% +$44.4K 0.73% 43
2018
Q4
$1.65M Sell
22,683
-1,177
-5% -$83.1K 0.73% 43
2018
Q3
$1.61M Buy
23,860
+53
+0.2% +$3.38K 0.62% 53
2018
Q2
$1.38M Sell
23,807
-1,456
-6% -$82.1K 0.6% 50
2018
Q1
$1.31M Sell
25,263
-2,725
-10% -$147K 0.58% 48
2017
Q4
$1.5M Buy
27,988
+1,084
+4% +$60.1K 0.55% 47
2017
Q3
$1.64M Hold
26,904
0.67% 40
2017
Q2
$1.65M Sell
26,904
-666
-2% -$40.5K 0.62% 46
2017
Q1
$1.67M Buy
27,570
+53
+0.2% +$3.21K 0.7% 42
2016
Q4
$1.55M Buy
27,517
+861
+3% +$50.4K 0.69% 44
2016
Q3
$1.59M Buy
26,656
+2,473
+10% +$145K 0.74% 42
2016
Q2
$1.33M Sell
24,183
-2,531
-9% -$135K 0.78% 42
2016
Q1
$1.35M Buy
26,714
+1,798
+7% +$88.1K 0.71% 43
2015
Q4
$1.26M Buy
24,916
+524
+2% +$26.4K 0.72% 44
2015
Q3
$1.15M Buy
24,392
+209
+0.9% +$11.1K 0.62% 48
2015
Q2
$1.31M Hold
24,183
0.67% 46
2015
Q1
$1.33M Hold
24,183
0.68% 47
2014
Q4
$1.31M Hold
24,183
0.66% 45
2014
Q3
$1.37M Sell
24,183
-32
-0.1% -$1.8K 0.73% 44
2014
Q2
$1.34M Buy
24,215
+32
+0.1% +$1.75K 0.69% 44
2014
Q1
$1.31M Buy
24,183
+1,829
+8% +$94.7K 0.72% 45
2013
Q4
$1.07M Sell
22,354
-85
-0.4% -$3.88K 0.61% 49
2013
Q3
$1.02M Buy
22,439
+143
+0.6% +$6.53K 0.67% 46
2013
Q2
$988K Buy
+22,296
New +$996K 0.64% 46

Other funds holding MRK

Ironwood Investment Counsel's MRK Position: Q2 2026 in Review

Ironwood Investment Counsel increased its Merck (MRK) stake by 0.85% in Q2 2026, buying an estimated $46.8K and bringing the position to 47,608 shares worth $6.12M. The position accounts for 0.8% of the portfolio, ranked #36.

Ironwood Investment Counsel first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.74M in Q1 2024. 2,385 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ironwood Investment Counsel held 47,608 shares of Merck worth $6.12M as of Q2 2026.
  • Ironwood Investment Counsel bought 400 Merck shares in Q2 2026, an estimated $46.8K.
  • Merck made up 0.8% of Ironwood Investment Counsel's portfolio in Q2 2026, its #36 holding.
  • Ironwood Investment Counsel first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Ironwood Investment Counsel's Merck position peaked at $9.74M in Q1 2024.
  • 2,385 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ironwood Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.